Get started
Author

Joseph Walton

Observed names: Joseph Paul Walton, Walton, Joseph Paul
ORCID: 0000-0002-4654-4404
Observed ORCID: 0000-0002-4654-4404
OpenAlex ID: A5032932437
PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
2022 · Joseph Walton, Keith Lawson, et al. · Nature Reviews Urology · 63
PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma
2024 · Joseph Walton, Angel S. N. Ng, et al. · Nature Communications · 16
PDF
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes
2024 · Matthew Waas, Christina Karamboulas, et al. · Nature Communications · 12
PDF
PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agents
2025 · Mansi K. Aparnathi, Sami Ul Haq, et al. · Neoplasia · 8
RASSF1A loss in ccRCC: genomic instability and the role of chromosome 3p
2025 · Joseph Walton, Laurie Ailles · Kidney International · 1
Abstract 7130: Dysregulated DNA repaired elicited by type 1 PRMT inhibitor in clear cell renal cell carcinoma enables development of novel combination therapies
2024 · Karen Arevalo, Joseph Walton, et al. · Cancer Research
Abstract 3226: PRMT1 is a critical dependency in clear cell renal cell carcinoma with roles in post- transcriptional regulation and DNA damage response
2024 · Joseph Walton, Karen Arevalo, et al. · Cancer Research
Targeting Epigenetic Regulation in Clear Cell Renal Cell Carcinoma Reveals PRMT1 as a Novel Target
2023 · Walton, Joseph Paul · TSpace (University of Toronto)
Abstract 1766: Targeting epigenetic regulation in clear cell renal cell carcinoma reveals PRMT1 as a novel target
2020 · Joseph Paul Walton, Anthony Apostoli, et al. · Cancer Research
Works count: 9
Citation count: 100
H-index: 4
I10-index: 3
Year
Topic
Type